Yuan Zhi
Stock Analyst at B. Riley Securities
(1.62)
# 3,414
Out of 5,044 analysts
27
Total ratings
38.46%
Success rate
-0.98%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $29.75 | -26.05% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $4.70 | +27.66% | 1 | Jul 16, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $2.73 | +339.56% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $78.84 | -12.48% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.16 | -13.79% | 2 | May 15, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $5.01 | +199.40% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $7.83 | +2.17% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.85 | +367.53% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $9.24 | +62.34% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.78 | +283.68% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $29.79 | +165.19% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.46 | +995.89% | 4 | Dec 11, 2023 |
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $29.75
Upside: -26.05%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $4.70
Upside: +27.66%
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $2.73
Upside: +339.56%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $78.84
Upside: -12.48%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.16
Upside: -13.79%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $5.01
Upside: +199.40%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $7.83
Upside: +2.17%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.85
Upside: +367.53%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $9.24
Upside: +62.34%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.78
Upside: +283.68%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $29.79
Upside: +165.19%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.46
Upside: +995.89%